Resources/Diabetes
Condition Guide

Diabetes

The FAA can certificate pilots with diabetes — including those on insulin. What matters is control, safety record, treatment regimen, and documentation of stability.

Informational Use Only. The information on this page reflects our understanding of current FAA medical certification requirements and is provided for general educational purposes only. FAA policies, the AME Guide, and special issuance protocols are updated frequently and without notice. The FAA AME Guide and FAA Civil Aerospace Medical Institute (CAMI) are the authoritative sources in all cases. Nothing on this page constitutes legal or medical advice. Always verify current requirements directly with your Aviation Medical Examiner and the official FAA AME Guide at faa.gov/ame_guide before making any certification decisions.

Initial Certification Always Requires FAA Decision

For initial medication-treated diabetes, the AME must DEFER for FAA review and possible Special Issuance; subsequent issuance follows the FAA authorization. For initial non-insulin therapy, the current medication-group table specifies metformin only (Group B): 14 days; Groups C–G: 30 days; Group A2: 60 days. Adding a Group B–G drug to an established Group A–G regimen requires 14 days; adding Group A2 requires 60 days. Dose, formulation or within-class changes require 48 hours within Groups B–G or 7 days within Group A2. These intervals do not replace the full protocol or confer permission to fly.

Quick Triage: Where Do You Stand?

Your treatment type is the primary driver of your documentation pathway.

1

Controlled by diet and exercise only — no medications

Simpler pathway
2

Oral medications or non-insulin injectables (e.g., metformin, GLP-1s)

FAA decision required
3

Insulin-treated diabetes

Structured protocol
4

Any hypoglycemia requiring external assistance or ER visit

Significant review factor
5

Complications present (eye, kidney, nerve, or cardiovascular)

Additional documentation

The Acceptable Combinations Rule

The FAA publishes an Acceptable Combinations of Diabetes Medications chart that defines which drug combinations are permitted. Key rules include:

  • No more than one medication from certain drug groups may be used simultaneously
  • Some newer drug classes have specific restrictions or require FAA decision
  • Any combination outside the acceptable framework requires full FAA Special Issuance review
  • A new medication or combination resets the stability clock
View FAA Diabetes AME Guide Page

What the FAA Evaluates

The FAA's primary concern is incapacitation risk — especially from hypoglycemia. Their review focuses on whether your management is stable, documented, and safe.

Glycemic Control

For non-insulin treatment, provide A1C within 90 days of the exam and more than 30 days after medication changes. Additional trends, glucose logs or CGM data depend on the applicable protocol and authorization; a 12-month lab history is not universally required.

Hypoglycemia Risk & History

Any episode requiring assistance from another person or emergency care is a significant review factor. The FAA wants to understand cause, response, and what changed in your management.

Treatment Regimen Stability

How long you've been on your current regimen, any recent changes, and whether your management plan has been stable enough to establish a reliable safety baseline.

Complications

Diabetic eye disease, kidney disease, peripheral neuropathy, and cardiovascular involvement each require specific additional evaluation. The FAA reviews complication status as part of the overall risk picture.

Monitoring Evidence

Documentation that you actively monitor your glucose — meter logs, CGM reports, or clinician notes referencing monitoring habits — demonstrates active management.

Treating Physician Oversight

Regular follow-up with an endocrinologist or diabetes specialist, with timely A1C checks and medication adjustments, reflects a well-managed condition.

What to Gather

Treating Clinician Summary
Diagnosis date and type (Type 1, Type 2, LADA, etc.)
Current medication regimen and start dates
For non-insulin treatment: A1C within 90 days of the AME exam, more than 30 days after a medication change
History of any hypoglycemic episodes
Assessment of complications status
Clinician statement on stability and safety
Lab Results
Current non-insulin A1C within 90 days, more than 30 days after medication changes; additional history if required by your protocol or authorization
Fasting blood glucose readings
Kidney function labs (eGFR, creatinine)
CGM download or glucose meter logs if available
Medication Documentation
Complete current medication list
Start dates for each agent
Any recent changes or additions
Confirm alignment with FAA acceptable combinations
If Insulin-Treated
Insulin regimen detail: type, dose, timing
CGM data or glucose log demonstrating control
Documentation of hypoglycemia events (or absence)
Ophthalmology evaluation for diabetic eye disease
Expect additional FAA protocol requirements

Common Pitfalls

Medication combination outside FAA's acceptable framework — must be resolved before submission

Undisclosed hypoglycemia episode that later appears in medical records

No documentation of stability after a regimen change

Missing ophthalmology evaluation when required for complications review

Patient portal summary submitted instead of formal clinic notes and lab reports

Outdated or premature A1C documentation — for non-insulin treatment, submit a result within 90 days and more than 30 days after medication changes; follow any additional authorization requirements

Frequently Asked Questions

Why Choose Chester Medical?

What sets our practice apart for diabetes certification cases.

HIMS Senior AME

FAA-designated HIMS Senior AME with experience across the full range of diabetes certification cases — diet-controlled through insulin-treated.

Pilot, Not Just a Physician

Active corporate jet pilot (ATP, CFI, CFII, MEI) — understands the operational stakes of glucose management in the cockpit.

Direct Physician Access

You work directly with the doctor. No case managers, no handoffs — one point of contact from consultation through certification.

Remote Consultations

Consultations available remotely for pilots nationwide to review their case before traveling for an exam.

Modern Patient Portal

A digital patient portal for HIMS phase tracking, document management, and progress visibility.

Two Arizona Locations

Flagstaff and Lake Havasu City offices — serving pilots across the Southwest and beyond.

Questions about your specific situation?

This page is general education only — individualized guidance is provided in a scheduled consultation.

Chester Medical Corporation

FAA AME HIMS Program · Copyright © 2026